Neonatal Abstinence Syndrome:
Part 2- Management of Infants with NAS, Therapeutic Interventions

  • Register
  • Description
  • TEST YOUR CONNECTION!

Register for our webinars on Neonatal Abstinence Syndrome (NAS):

Part 1- Assessment of Infants with NAS
VIEW-ON-DEMAND VIDEO

Part 2- Management of Infants with NAS, Therapeutic Interventions
Wed, May 2, 2018 at 12:00 PM ET


      
 = Required fields

Supported by: Philips Healthcare
Yes! Please keep me informed of news, products, and promotions from Philips Healthcare.
  Yes! I agree to the Philips Terms of Use and Privacy Policy

By clicking the "Submit" button you submit your information to the Webinar organizer
who will use it to communicate with you regarding this event and their other services.


HELPFUL TIPS:
Sometimes, Insufficient User Privileges ~OR~ secure HIPPA networks might deactivate Registration Form Submit Buttons.

If your button stays Gray (or is missing) AFTER providing all required data, PLEASE TRY one of these two things:

  1. Either, Forward your Registration Link or email Invitation to your personal email account to try
    using the Registration Form from Home or from any Non-work internet connection;
  2. Or, Send an Email with ALL of Your Registration Information for Each Data Field on the form
    to: Producer@WebinarCreativeTechnology.com


If you have problems with this page, or do not get a registration confirmation within a few minutes, or if you need any
technical help registering, please contact us right away! NOTE: Not all devices or browsers are compatible.

CALL Emily Eberly at: 513-579-0800, or send an email to: Producer@WebinarCreativeTechnology.com

For Live Broadcast Events:
REGISTRATION ENDS: 2 Hours BEFORE the Start-time of the webinar broadcast, PLEASE Register Early!

SERVICE GUARANTEE: Help is Guaranteed ONLY up to 4 hours before Broadcast time.

TEST YOUR COMPUTER’S CONNECTION HERE: http://replay.center/howto.php


Webinar organizers are prohibited from soliciting confidential personal information (credit card information,
social security numbers, etc.) in the registration form. This questionnaire is not intended to handle sensitive data.



Karen D’Apolito, PhD
CNEs for Nurses

Please Register to ACCESS our Free CE Accredited Webinar REPLAY


Our Speaker:
Karen D’Apolito, PhD, NNP-BC, FAAN
Director, Neonatal NP Specialty
Vanderbilt University School of Nursing
Nashville, TN


VIDEO REPLAY, Part 1: Assessment of Infants with Neonatal Abstinence Syndrome (NAS)


Description:
Drug use among pregnant women can lead to problems in the developing fetus including congenital anomalies, problems with growth, preterm labor, withdrawal or toxicity in the newborn, and later problems with neurodevelopment. One of the most readily apparent problems created by in utero exposure to drugs is neonatal abstinence syndrome. This presentation will discuss the definition of NAS, the drugs that may cause signs of neonatal abstinence, screening methods and the use of the Finnegan scoring tool to assess the severity of withdrawal signs and the importance of being reliable when scoring.

Learning Objectives:
After the completion of this activity, the participant will be able to:

  1. Define neonatal abstinence syndrome.

  2. Identify the incidence and hospital costs of infants with NAS.

  3. Describe the Finnegan scoring tool and how it is used to assess infants with NAS.


Bio: Karen D’Apolito, PhD, NNP-BC, FAAN
Dr. Karen D’Apolito is currently the Director, Neonatal NP Specialty, School of Nursing at Vanderbilt University in Nashville, TN. She has served on the Board of Directors of the National Association of Neonatal Nurses (NANN) and was instrumental in the development of neonatal nursing practice guidelines as Chairperson of the NANN Practice Committee.

Dr. D’Apolito has also served on the Board of the National l Perinatal Association and functioned as the Vice President for programs and Chair of the Advocacy Committee. Currently she is on the Executive Committee of the Academy of Neonatal Nursing.

In 2008, Dr. D’Apolito received the Individual Contribution to Maternal and Child Health Award from the National Perinatal Association for her work with drug-exposed infants. She has also developed an inter-observer reliability program for the Neonatal Abstinence Scoring Tool. She served as co-investigator on a multi-site NIH Grant designed to assess the severity of withdrawal in neonates born to women who were randomly treated during pregnancy with either methadone or buprenorphine.

Her research interests are in the area of infant adaptation and chemical dependency. She has had many publications in these areas and has published on the topic of neonatal pain.


Continuing Education for Nurses:
This education activity is approved for 1.0 contact hour.

Saxe Healthcare Communications is accredited as a provider for continuing education by the California Board of Nursing Provider #14477 and the Florida Board of Nursing Provider # 50-17032.

Educational support has been provided by Philips Healthcare.


Provided by © Saxe Healthcare Communications 2018
 
2018-05-02T16:00:00Z2018-05-02T17:00:00Z

Karen D’Apolito, PhD
CNEs for Nurses

Please join us for this free accredited educational event:


Our Speaker:
Karen D’Apolito, PhD, NNP-BC, FAAN
Director, Neonatal NP Specialty
Vanderbilt University School of Nursing
Nashville, TN


Part 2: Management of Neonatal Abstinence Syndrome (NAS): Therapeutic Interventions
Wednesday, May 2, 2018 at 12:00 PM ET

Description:
Neonatal Abstinence Syndrome (NAS) can be potentially severe and cause long hospital stays. Pharmacological interventions are commonly used as treatment and their safety and efficacy is continuing to be studied. Non-pharmacologic interventions and complementary therapies have also been documented. This presentation will discuss the pharmacologic and non-pharmacologic goals of treating infants with NAS. There will also be a discussion of the most common drugs used to manage signs of withdrawal and two different strategies, weight based vs sign based, to determine when pharmacologic treatment is needed. Additionally, nurse-driven interventions including swaddling, kangaroo care, low stimuli and breastfeeding will also be discussed.

Learning Objectives:
After the completion of this activity, the participant will be able to:

  1. Identify the goal of pharmacologic and non-pharmacologic treatment of NAS.

  2. Discuss the nurse-driven interventions (non-pharmacologic) to support the infant with NAS.

  3. Describe two different strategies for treating infants with NAS pharmacologically.


Bio: Karen D’Apolito, PhD, NNP-BC, FAAN
Dr. Karen D’Apolito is currently the Director, Neonatal NP Specialty, School of Nursing at Vanderbilt University in Nashville, TN. She has served on the Board of Directors of the National Association of Neonatal Nurses (NANN) and was instrumental in the development of neonatal nursing practice guidelines as Chairperson of the NANN Practice Committee.

Dr. D’Apolito has also served on the Board of the National l Perinatal Association and functioned as the Vice President for programs and Chair of the Advocacy Committee. Currently she is on the Executive Committee of the Academy of Neonatal Nursing.

In 2008, Dr. D’Apolito received the Individual Contribution to Maternal and Child Health Award from the National Perinatal Association for her work with drug-exposed infants. She has also developed an inter-observer reliability program for the Neonatal Abstinence Scoring Tool. She served as co-investigator on a multi-site NIH Grant designed to assess the severity of withdrawal in neonates born to women who were randomly treated during pregnancy with either methadone or buprenorphine.

Her research interests are in the area of infant adaptation and chemical dependency. She has had many publications in these areas and has published on the topic of neonatal pain.


Continuing Education for Nurses:
This education activity is approved for 1.0 contact hour.

Saxe Healthcare Communications is accredited as a provider for continuing education by the California Board of Nursing Provider #14477 and the Florida Board of Nursing Provider # 50-17032.

Educational support has been provided by Philips Healthcare.


Provided by © Saxe Healthcare Communications 2018

System Requirements


PC-based attendees
Windows® 7 - 10
Mac®-based attendees
Mac OS® X 10.9 (Mevericks) - 10.11 (El Capitan)
Mobile attendees
iPhone®, iPad®, Android™ phone or Android tablet
TEST YOUR COMPUTER’S CONNECTION HERE: http://replay.center/howto.php

Your email address and personal information will be used by the Webinar organizer to communicate with you about this event and their other services. To review the Webinar organizer's privacy policy or opt out of their other communications, contact the Webinar organizer directly.


Safeguarding your email address and Webinar registration information is taken seriously at GoToWebinar.
GoToWebinar will not sell or rent this information.


GoToWebinar and GoToMeeting are now part of GetGo, Inc., a subsidiary of LogMeIn, Inc.

View the GoToWebinar Privacy Policy.